Introduction
The K-ras gene is frequently mutated in lung adenocarcinoma as well as in cancers of the pancreas, colon and other tissues. Transgenic expression of mutant K-ras in the mouse lung led to rapid development of multiple tumors (1--4) . However, wild-type K-ras is a tumor suppressor in mouse lung (5) . How then does mutant K-ras act as a dominant oncoprotein? Several studies demonstrated that expression of a constitutively active mutant of H-ras led to an increase in reactive oxygen species (ROS) generation in fibroblasts (6--11) , keratinocytes (12) and kidney epithelial cells (13, 14) . V-Ki-ras also caused a marked increase in ROS in fibroblasts (9) .
Malignant transformation of kidney cells by v-H-ras was suppressed by over-expression of anti-oxidant enzymes superoxide dismutase or glutathione peroxidase (14) . ROS are known to react with various intracellular targets, including lipids, proteins and DNA. ROS may contribute to the transformation by causing DNA damage. These observations led us to the hypothesis that mutant K-ras might cause an increase in ROS and DNA damage in lung epithelial cells, and in this way lead to transformation.
Preliminary experiments supported this hypothesis: ROS as peroxides were significantly increased in peripheral lung epithelial cells expressing mutant K-ras V12 , compared with controls. However, superoxides were not increased, and an inhibitor of flavoproteins had no effect, eliminating several usual sources of ROS, including the mitochondrial electron transport system and NAD(P)H oxidase. An attractive remaining candidate was cyclooxygenase-2 (COX-2), expected to be a direct producer of peroxides. Several studies have reported the induction of COX-2 in association with activated H-ras (15--18) . A relationship between COX-2 expression and K-ras mutation has been found in colorectal adenomas (19) . We therefore hypothesized that the observed increase in ROS in K-ras V12 transfected lung cells was due to the up-regulation of COX-2.
Materials and methods
Cell lines and stable transfection with human K-ras V12 and human WT-K-ras
The E10 cell line was originally derived from explants of BALB/c female mouse lung (20, 21) and was obtained from Dr Randall Ruch, Medical College of Ohio. The cells and the clones derived from E10 transfected with human K-ras V12 or wild-type K-ras in pCMV-Tag1 Vector (Stratagene, La Jolla, CA) were maintained at 37 C and 5% CO 2 in Connaught Medical Research Laboratories (CMRL) 1066 medium (BioFluids, Rockville, MD) supplemented with 4 mM glutamine, penicillin (100 U/ml), streptomycin (100 mg/ml) and 10% fetal bovine serum (Gemini Bio-Products, Woodland, CA). For transfection, the E10 cells were seeded in 10 cm Petri dishes and allowed to grow for 24 h tõ 60% confluence. The cells were transfected with 3 mg human K-ras V12 or WT K-ras construct in 6 ml FuGENE 6 Transfection Reagent (Roche Diagnostics, Indianapolis, IN). Individual neomycin-resistant colonies were isolated by ring cloning. Clones with high expression of the hK-ras V12 construct were identified by RT--PCR with human K-ras specific primers (upper primer: 5 0 GAC TGA ATA TAA ACT TGT GGT A 3 0 , lower primer: 5 0 CTA TTG TTG GAT CAT ATT GC 3 0 ) with 40 cycles utilized for semi-quantitative assessment.
Determination of peroxides generation
The intracellular level of peroxides was quantified by the oxidation of the peroxide-sensitive fluorophore 5,6-chloromethyl-2 0 ,7 0 -dichlorodihydrofluorescein diacetate (CM-H 2 DCF-DA) (Molecular Probes, Eugene, OR). Cells were loaded with 5 mM CM-H 2 DCF-DA in Hanks' balanced salt solution (HBSS) at 37 C and 5% CO 2 . After 20 min of incubation the cells were harvested with trypsin--EDTA and 2 0 ,7 0 -dichlorofluorescein (DCF) fluorescence was analyzed immediately by flow cytometry with the excitation source at 488 nm and emission at 530 nm. All experiments were performed three times, each time in triplicate.
Determination of superoxide production A modified version of a previously described assay for the intracellular conversion of nitroblue tetrazolium (NBT) to formazan by superoxide anion was used to measure the level of superoxide (22 incubated with 0.5 mg/ml NBT (Roche) in HBSS for 30 min, rinsed three times with methanol to remove unreduced NBT, fixed in absolute ethanol, and allowed to air dry. The formazan content of the cells was then solubilized with 480 ml 2 M KOH and 560 ml dimethyl sulfoxide (DMSO) and the absorbance at 630 nm was measured spectrophotometrically. A standard curve was prepared by adding KOH and DMSO to known amounts of NBT.
The NBT assay results were confirmed by dihydroethidium (DHE, Molecular Probes) staining. DHE is oxidized by superoxide to yield fluorescent ethidium (excitation 475 nm/emission 610 nm). The cells were incubated with 5 mM DHE for 30 min, then the dye containing HBSS was removed, cells rinsed and fresh medium was added. The ethidium fluorescence was observed under an inverted fluorescent microscope Zeiss Axiovert 200 M (Carl Zeiss, Thornwood, NY).
Prostaglandin E 2 assay
The cells were seeded into 6-well culture dishes and allowed to grow for 24 h to 70% confluence. The culture medium was replaced with fresh medium (3 ml/well) and after desired time intervals (indicated in the figure legends) an aliquot of culture medium was removed from each well and any particulate was removed by centrifugation. Prostaglandin E 2 (PGE 2 ) level in the culture medium was measured using a PGE 2 competitive enzyme immunoassay (Cayman Chemicals, Ann Arbor, MI) according to the manufacturer's protocol. Each experiment was performed in triplicate and the mean PGE 2 values are shown as the final results.
COX-2 protein immunoblotting
For protein immunoblotting the cells were harvested in lysis buffer [25 mM HEPES buffer containing 150 mM NaCl, 10 mM MgCl 2 , 1% Nonidet P-40, 0.25% sodium deoxycholate, 10% glycerol, 2.5 mM EDTA, 0.28 TIU/ml aprotinin, 10 mM NaF, 2 mM phenylmethylsulfonyl fluoride (PMSF) and 2 mM Na--orthovanadate]. Cell lysates (5 mg) were resolved by SDSpolyacrylamide gel electrophoresis (12% Tris--glycine gel, Invitrogen Life Technologies, Carlsbad, CA) and immunoblotted with polyclonal antibody to COX-2 (1:2000) (Santa Cruz Biotechnology, Santa Cruz, CA).
Assay for active K-ras p21 K-ras activity assay was performed as described previously (23) with modification. Total cell lysate (500 mg of protein) was incubated with 30 mg of Raf1-RBD (Upstate Biotechnology, Lake Placid, NY) for 1 h at 4 C. The beads were pelleted by centrifugation and washed three times with lysis buffer. The bound proteins were eluted by boiling in Laemmli's buffer containing 50 mM dithiothreitol and subjected to SDS--PAGE followed by immunoblotting with monoclonal antibody to K-ras (1:2000) (Oncogene Science, Uniondale, NY).
Comet assay
The alkaline comet assay was performed using a modification of the method of Singh (24) . The cells suspended in HBSS at 2 Â 10 5 /ml were mixed 1:10 with 0.8% low melting point agarose and layered onto comet slides (Trevigen, Gaithersburg, MD). The slides were placed into a chilled lysing solution (2.5 M NaCl, 100 mM Na 2 EDTA, 10 mM Tris-base, 1% sarcosyl, 10% DMSO and 1% Triton X-100, pH 10) and lysed overnight at þ4 C in the dark. After 15 min of unwinding in alkaline solution (300 mM NaOH, 1 mM Na 2 EDTA, pH 12.1) the slides were subjected to electrophoresis at 0.8 V/cm for 20 min. The slides were neutralized with 0.4 M Tris--HCl, pH 7.4, dehydrated with ethanol and allowed to air-dry, then stained with SYBR Gold (1:10 000, Molecular Probes, Eugene, OR). Each experiment was performed in triplicate. Typically 100 cells were analyzed per sample. Comets were observed under fluorescent microscope Zeiss Axiovert 200 M and images were captured with AxioCam MRm digital camera. The comet tail intensity was quantified using Labworks 4.0 software (UVP, Upland, CA).
Treatment with chemicals
The cells were seeded into 6-well culture dishes and allowed to grow to 70--80% confluence. For the experiment with the COX-2-specific inhibitor SC58125 (25) (Calbiochem Biosciences, La Jolla, CA) the cells were treated with 10 nM, 100 nM, 1 mM or 10 mM SC58125 in complete medium for time periods indicated in the figure legends, then subjected to assay for PGE 2 , peroxides or Comet assay. For the experiments with diphenylene iodonium (DPI) (Sigma Chemical, St Louis, MO), cells were treated with 20 mM DPI for 20 min, followed by DCF assay in the presence of DPI.
Statistical analyses
Data in all experiments are represented as mean AE SE. Statistical comparisons were carried out using ANOVA with Bonferroni correction using GraphPad InStat 3.0 (GraphPad Software, San Diego, CA). P values 50.05 were considered to be statistically significant. Regression analysis was performed using the Pearson test.
Results
We stably transfected mouse lung E10 epithelial cells with human mutant K-ras V12 . Individual derived clones carrying the mutant K-ras gene (designated 61-28, 61-29 and 73-13) were compared with a clone carrying empty vector only (60-1) and the parental E10 line. Expression of constitutively active human mutant K-ras V12 in these cells resulted in a significant, 2-fold increase in intracellular level of peroxides, as indicated by fluorescence of DCF, an oxidized derivative of H 2 DCF-DA (Figure 1) . To check whether wild-type K-ras over-expression can also induce production of intracellular ROS, we used the 8-10 cell line, which is a stable transfectant of E10 cells with human WT K-ras. We did not observe any increase in DCF fluorescence in 8-10 cells (Figure 1 ). This strongly indicates that induction of peroxides generation in these lung cells is a specific effect of mutant K-ras.
To determine if the activated K-ras V12 induced DNA damage in our lung epithelial cells we employed the comet assay to measure DNA strand breaks. K-ras V12 transfected cells showed a significant increase in DNA single strand break level in comparison with the parental E10 line and to the vector control ( Figure 2 ).
The next question was the source of the peroxides. H 2 O 2 can be generated by spontaneous or superoxide dismutasecatalyzed dismutation of superoxide. We used two different methods to determine if superoxide was involved: the nitroblue tetrazolium reduction method and dihydroethidium staining. We did not observe any increased NBT reduction ( Figure 3A) , or any increase in the level of ethidium fluorescence ( Figure 3B ) in the cells expressing K-ras V12 . This indicates that superoxide was not the source of H 2 O 2 giving DCF signal. We also found no evidence that a flavoprotein is involved in ROS production in K-ras V12 transfectants: treatment of the cells with DPI, a flavoprotein inhibitor, did not affect peroxides' level ( Figure 3C ).
Peroxides may also be directly generated by COX-2 (26), an enzyme that has frequently been observed as induced by ras expression (15--18) . We therefore attempted to determine whether COX-2 could be a source of peroxides in the K-ras V12 transfectants. Expression of COX-2 protein was elevated in the Figure 4A ). COX-2 activity measured as prostaglandin E 2 level was significantly higher in K-ras V12 transfectants than in controls ( Figure 4B ). COX-2 activity in these cells correlated significantly with K-ras activity ( Figure 4C and D) .
From these results, we concluded that transfection of constitutively active K-ras V12 mutant into E10 cells led to up-regulation of COX-2 and postulated that the increased level of peroxides was a by-product of COX enzymatic activity.
To confirm that COX-2 was the source of peroxides in the K-ras V12 transfected cells, we treated the cells with COX-2-specific inhibitor, SC58125. We used four different concentrations of SC58125, within the range of between 10 nM and 10 mM. The cells were counted after treatment with inhibitor to confirm that SC58125 did not cause any cell loss due to its toxicity. The cell count was unaltered with all Figure 5B ). Even the lowest dose of SC58125, 10 nM, reduced PGE 2 production to control levels ( Figure 5A ) and significantly reduced DCF fluorescence ( Figure 5B ). This strongly confirms that COX-2 was responsible for the increased production of peroxides resulting from mutant K-ras V12 expression. The decrease in DCF fluorescence strongly correlated with the decrease in COX-2 activity measured as PGE 2 level (r ¼ 0.90 at P 5 0.0001) ( Figure 5C ). The residual DCF fluorescence is probably due to the fact that CM-H 2 DCF-DA and SC58125 had to be added simultaneously to the cells; thus some oxidation of H 2 DCF-DA occurred before the full inhibitory effect of SC58125 was achieved.
Furthermore, the increase in DNA strand break damage was significantly reduced by treatment with the COX-2-specific inhibitor SC58125 (Figure 6 ), confirming COX-2 involvement in the mutant K-ras-dependent DNA damage. Within 30 min after addition of 10 mM SC58125, most of the increase in DNA damage related to K-ras mutant has been corrected; after 30 min of treatment the level of DNA strand breaks in mutant K-ras carrying line 73-13 did not differ significantly from that observed for vector control ( Figure 6 ). About 50% of the repair occurred between 5 and 15 min after addition of SC58125. Lower concentrations of SC58125 were less effective in reducing DNA damage detected by Comet assay (not shown).
In conclusion, the results suggest that ROS generation, through COX-2 up-regulation, may contribute to the active oncogenicity of mutant K-ras in the lung as a result of DNA damage.
Discussion
In this study we show that expression of human mutant K-ras V12 in mouse lung epithelial E10 cells led to generation of peroxides. Several previous studies reported generation of ROS as an effect of activated ras signaling. Fibroblasts or keratinocytes stably transfected with a constitutively active H-ras produced large amounts of superoxide (6--8) and NADPH oxidase was a possible source of ROS. We also show that mutant K-ras-induced ROS generation leads to DNA single strand break damage. This may cause mutations and possibly other genetic changes resulting in cell transformation.
COX-2 appeared to be the source of the increased level of peroxides in the K-ras V12 transfected cells. COX-2 has frequently been observed as induced by ras expression, including activated H-ras and K-ras transfected into fibroblasts or rat intestinal epithelial cells (15--18) . Morphological transformation was associated with rapid induction of COX-2 in fibroblasts and intestinal epithelial cells transformed by mutated H-ras, and in the latter cells the specific COX-2 inhibitor SC58125 reduced tumor growth (15) . However, there has been no report showing an increase in ROS generation in H-ras or K-ras transfectants with elevated COX-2 expression. COX-2 is an intracellular enzyme that directly generates peroxides, as was evidently occurring in our cells. Furthermore, COX-2 has been implicated in lung cancer, and lung cancer clinical trials of COX-2 inhibitors are in progress (27--34) .
Although a relationship between the over-expression of COX-2 and carcinogenesis has been suggested by several studies, the precise mechanism for this process is the subject of ongoing investigation. Most work has focused on the signaling effects of the eicosanoid products of COX-2 activity, related to cell division, apoptosis, invasion, etc. (32--34) . However, it has also been shown that DNA and/or nucleosides can be oxidized when incubated in vitro with COX-2 and arachidonic acid (26) . Inhibitor studies implicated COX-2 in DNA damage in human lung adenocarcinoma CL-3 cells (35) . In smokers, the oxidative activity of COX could also lead to bioactivation of smoke carcinogens such as polycyclic aromatic hydrocarbons and aromatic amines (32) . This mechanism of carcinogen activation is particularly significant in cells/tissues with low cytochrome P450 activity, such as lung. A role for COX-2 in the initiation stages of lung cancer development and in association with K-ras, via oxidative DNA damage and/or carcinogen activation, is supported by its up-regulation in atypical alveolar epithelium (27) , in pre-neoplastic lesions (27, 29) , and in early stage lung cancers and surrounding tissue, especially adenocarcinomas (31, 33, 36) where K-ras is frequently mutated. Similar observations were made in lung tumor-prone A/J mice (37) . Three human lung cancer cell lines with K-ras mutation expressed COX-2 highly and their growth was reduced by the COX-2 inhibitor sulindac sulfide (38) . Reduced incidence of lung carcinoma has been reported in cases of prolonged use of aspirin, a non-selective COX inhibitor (39) , and both the non-specific COX inhibitor acetylsalicylic acid and the COX-2-specific inhibitor NS-398 inhibited lung tumor causation in mice by the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (40) . On the other hand, celecoxib, a COX-2 inhibitor, did not suppress development of mouse lung tumors caused by urethane or 3-methylcholantrene plus butylated hydroxytoluene (41) . The nature and incidence of K-ras mutations were not reported for the latter study.
In conclusion, our results associate, for the first time, ROS release by COX-2 with DNA damage in an important cancer target cell. Induction of COX-2 by mutant K-ras, with resultant increase in ROS and DNA damage, may be part of its mechanism of active oncogenicity in the lung. These results support COX-2 as an attractive target for chemoprevention and intervention strategies. 
